|
MARKETWATCH
Riding The Rollercoaster: The Ups And Downs In Out-Of-Pocket Spending Under The Standard Medicare Drug Benefit
Bruce Stuart,
Becky A. Briesacher,
Dennis G. Shea,
Barbara Cooper,
Fatima S. Baysac and
M. Rhona Limcangco
This study projects how much Medicare beneficiaries who sign up for the standard Part D drug benefit in 2006 will pay in quarterly out-of-pocket payments through 2008. In the first year we estimate that about 38 percent of enrollees will hit the benefit’s no-coverage zone, known as the "doughnut hole," and that 14 percent will exceed the catastrophic threshold. Because drug spending is highly persistent over time, beneficiaries who experience the biggest gaps in coverage are likely to do so year after year, with potentially serious financial consequences.
       What's this?
This article has been cited by other articles:
|
|
|
|
 
D. J. Cobaugh, E. Angner, C. I. Kiefe, M. N. Ray, C. L. LaCivita, N. W. Weissman, K. G. Saag, and J. J. Allison
Effect of racial differences on ability to afford prescription medications
Am. J. Health Syst. Pharm.,
November 15, 2008;
65(22):
2137 - 2143.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
H. Chen, A. Nwangwu, R. Aparasu, E. Essien, S. Sun, and K. Lee
The Impact of Medicare Part D on Psychotropic Utilization and Financial Burden for Community-Based Seniors
Psychiatr Serv,
October 1, 2008;
59(10):
1191 - 1197.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
L.I. Iezzoni, L.H. Ngo, and R.P. Kinkel
Working-age persons with multiple sclerosis and access to disease-modifying medications
Multiple Sclerosis,
January 1, 2008;
14(1):
112 - 122.
[Abstract]
[PDF]
|
|
|
|
|
|
|
F. R. Lichtenberg and S. X. Sun
The Impact Of Medicare Part D On Prescription Drug Use By The Elderly
Health Aff.,
November 1, 2007;
26(6):
1735 - 1744.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
P. Neuman, M. K. Strollo, S. Guterman, W. H. Rogers, A. Li, A. M. C. Rodday, and D. G. Safran
Medicare Prescription Drug Benefit Progress Report: Findings From A 2006 National Survey Of Seniors
Health Aff.,
September 1, 2007;
26(5):
w630 - w643.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
J. M. Rosenberg
Overview of Medicare Part D prescription drug benefit: Potential implications for patients with psychotic disorders
Am. J. Health Syst. Pharm.,
January 15, 2007;
64(2_Supplement_1):
S18 - S23.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
U. D. Patel and M. M. Davis
Falling into the Doughnut Hole: Drug Spending among Beneficiaries with End-Stage Renal Disease under Medicare Part D Plans
J. Am. Soc. Nephrol.,
September 1, 2006;
17(9):
2546 - 2553.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
D. Dranove and M. L. Millenson
Medical Bankruptcy: Myth Versus Fact
Health Aff.,
March 1, 2006;
25(2):
w74 - w83.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
W. F. Gellad, H. A. Huskamp, K. A. Phillips, and J. S. Haas
How The New Medicare Drug Benefit Could Affect Vulnerable Populations
Health Aff.,
January 1, 2006;
25(1):
248 - 255.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
